Actinogen Medical Limited
ATGGF
$0.03
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.32% | -76.57% | -2.12% | 22.66% | 2.75% |
| Total Depreciation and Amortization | 0.29% | -2.13% | 2.18% | 4.39% | -2.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.32% | 151.07% | -2.12% | -179.71% | -2.75% |
| Change in Net Operating Assets | -- | -- | 2.12% | -- | -- |
| Cash from Operations | -0.32% | 21.79% | -2.12% | -614.54% | -2.75% |
| Capital Expenditure | 0.00% | 92.11% | -1.79% | -1,300.00% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00% | 92.11% | -1.79% | -1,300.00% | 0.00% |
| Total Debt Issued | -- | -- | 0.00% | -- | -- |
| Total Debt Repaid | 0.00% | -10,104.49% | 0.00% | -6.12% | 0.00% |
| Issuance of Common Stock | 0.00% | -- | -- | -100.00% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 0.00% |
| Cash from Financing | -0.32% | -198.12% | 2.12% | -75.53% | -2.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.32% | -60.10% | -2.12% | -145.65% | -2.75% |